Axovant Sciences Ltd (AXGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AXGT | AZN | AMGN | GILD | BMY |
| Company | Axovant Sciences Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.12 | 188.47 | 340.75 | 127.96 | 57.69 |
| High | 2.17 | 189.65 | 349.45 | 132.21 | 60.56 |
| Low | 2.07 | 186.87 | 340.05 | 127.96 | 57.39 |
| Latest | 2.10 | 188.81 | 348.45 | 131.92 | 60.14 |
| Change | -0.05 | +3.61 | +10.43 | +3.08 | +2.55 |
| % Change | -2.33% | +1.95% | +3.09% | +2.39% | +4.43% |
| Volume | 490,900 | 1,260,617 | 888,879 | 1,438,744 | 8,040,885 |
| 20-Day Average Volume | 2,068,455 | 1,949,312 | 2,304,959 | 5,045,997 | 8,770,093 |
| Previous Close | 2.15 | 185.20 | 338.02 | 128.84 | 57.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.84 | 197.76 | 347.02 | 136.02 | 58.79 |
| 20-Day Raw Stochastic | 11.48% | 28.37% | 55.18% | 26.22% | 87.93% |
| 20-Day Relative Strength | 37.81 | 43.75 | 48.01 | 41.22 | 54.28 |
| Weighted Alpha | -44.70 | +27.59 | +22.36 | +22.31 | +25.28 |
| Today's Opinion | 40% Sell | 40% Buy | 24% Buy | 8% Buy | 72% Buy |
| Previous Opinion | 40% Sell | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 48% Buy | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.41% since 11/05/20 | -1.72% since 04/23/26 | -0.22% since 04/23/26 | -1.48% since 04/23/26 | +1.95% since 04/23/26 |
| Low | 1.90 on 11/10/20 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 2.18 on 11/06/20 | 190.59 on 04/27/26 | 348.94 on 04/30/26 | 132.32 on 04/24/26 | 60.56 on 04/30/26 |
| 1-Month | |||||
| %Chg | -42.93% since 10/12/20 | -2.52% since 03/30/26 | -0.33% since 03/30/26 | -3.43% since 03/30/26 | +0.74% since 03/30/26 |
| Low | 1.86 on 11/02/20 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 3.95 on 10/19/20 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -34.58% since 08/12/20 | +1.86% since 01/30/26 | +1.74% since 01/30/26 | -7.25% since 01/30/26 | +9.30% since 01/30/26 |
| Low | 1.86 on 11/02/20 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 5.74 on 10/05/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -37.31% since 05/12/20 | +14.76% since 10/30/25 | +19.12% since 10/30/25 | +11.16% since 10/30/25 | +31.89% since 10/30/25 |
| Low | 1.86 on 11/02/20 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 45.20 on 10/31/25 |
| High | 5.74 on 10/05/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,225 | 287,228,128 | 182,424,320 | 159,919,040 | 117,583,520 |
| Shares Outstanding, K | 47,250 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -72,630,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.55 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 11/13/20 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.38 | 15.54 | 15.86 | 9.47 |